Vanda Pharmaceuticals Inc
(NASDAQ:VNDA)
Johnson & Johnson (JNJ) sold assets to Vanda Pharma (VNDA) on Thursday, December 7, 2023 for $100.0M
$3.80
-0.17[-4.28%]
Last update: 5:40PM (Delayed 15-Minutes)
Get Real Time Here
$3.80
0[0.00%]
After-Hours
Open3.960Close3.760
Vol / Avg.822.078K / 1.248MMkt Cap218.622M
Day Range3.760 - 3.97052 Wk Range3.295 - 11.040

Vanda Pharma Stock (NASDAQ:VNDA) Earnings Dates and Earning Calls

Vanda Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 8

EPS

$0.000

Quarterly Revenue

$38.8M

Annual Revenue (as of Sep 30)

$211.9M

Earnings Recap

Vanda Pharma (NASDAQ:VNDA) reported its Q3 earnings results on Wednesday, November 8, 2023 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Vanda Pharma missed estimated earnings by 100.0%, reporting an EPS of $0.0 versus an estimate of $-0.04.

Revenue was down $26.50 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.16 which was followed by a 8.05% drop in the share price the next day.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings History

Analyze the earnings history of Vanda Pharma using advanced sorting and filters.

Date
time
ticker
Quarter
Prior EPS
Est EPS
Actual EPS
EPS Surprise
Prior Rev
Est Rev
Actual Rev
Rev Surprise
Get Alert
02/07/2024PMVNDAQ4$0.12$64.48MGet Alert
11/08/2023PMVNDAQ3$0.06-$0.04$0.00100.00%$65.32M$44.50M$38.81M-12.78%Get Alert
07/27/2023PMVNDAQ2$0.05-$0.13$0.03123.08%$64.39M$49.00M$46.06M-6.01%Get Alert
05/03/2023PMVNDAQ1-$0.11$0.06$60.19M$62.50MGet Alert
02/08/2023PMVNDAQ4$0.12$0.08$0.1250.00%$68.02M$67.60M$64.48M-4.61%Get Alert
11/02/2022PMVNDAQ3$0.14$0.09$0.06-33.33%$70.09M$71.00M$65.32M-8.00%Get Alert
08/03/2022PMVNDAQ2$0.17$0.11$0.05-54.55%$67.90M$67.00M$64.39M-3.90%Get Alert
05/05/2022PMVNDAQ1$0.15-$0.01-$0.11-1000.00%$62.67M$58.00M$60.19M3.78%Get Alert
02/23/2022PMVNDAQ4$0.15$0.08$0.1250.00%$67.65M$70.04M$68.02M-2.89%Get Alert
11/03/2021PMVNDAQ3$0.11$0.16$0.14-12.50%$60.31M$75.00M$70.09M-6.54%Get Alert
07/28/2021PMVNDAQ2$0.16$0.14$0.1721.43%$62.21M$69.75M$67.90M-2.65%Get Alert
05/05/2021PMVNDAQ1$0.01$0.15$0.150.00%$58.00M$68.50M$62.67M-8.51%Get Alert
02/10/2021PMVNDAQ4$0.08$0.14$0.157.14%$60.93M$64.00M$67.65M5.71%Get Alert
10/28/2020PMVNDAQ3$0.23$0.09$0.1122.22%$59.48M$63.95M$60.31M-5.70%Get Alert
08/05/2020PMVNDAQ2$0.21$0.16$59.06M$61.95M$62.21M0.41%Get Alert
05/06/2020PMVNDAQ1$0.06$0.01$47.71M$56.87M$58.00M1.99%Get Alert
02/25/2020PMVNDAQ4$0.26$0.11$0.08-27.27%$53.04M$59.57M$60.93M2.28%Get Alert
11/06/2019PMVNDAQ3$0.20$0.07$0.23228.57%$49.13M$58.32M$59.48M2.00%Get Alert
07/31/2019PMVNDAQ2$0.14$0.28$47.35M$54.15M$59.06M9.07%Get Alert
Q

When is Vanda Pharma (NASDAQ:VNDA) reporting earnings?

A

Vanda Pharma (VNDA) is scheduled to report earnings on February 7, 2024. The last reported earnings were for reported on November 8, 2023 for Q3.

Q

What were the latest earnings per share (EPS) for Vanda Pharma (NASDAQ:VNDA)?

A

The Actual EPS was $0.00, which beat the estimate of $-0.04.

Q

What were Vanda Pharma’s (NASDAQ:VNDA) revenues?

A

The Actual Revenue was $38.8M, which missed the estimate of $44.5M.

Browse earnings estimates, EPS, and revenue on all stocks.